IRIS
PISAPIA, PASQUALE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.422
NA - Nord America 5.322
EU - Europa 4.010
SA - Sud America 712
Continente sconosciuto - Info sul continente non disponibili 273
AF - Africa 120
OC - Oceania 10
Totale 16.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.070
SG - Singapore 2.866
RU - Federazione Russa 1.806
CN - Cina 1.146
IT - Italia 1.085
VN - Vietnam 1.013
HK - Hong Kong 570
BR - Brasile 569
DE - Germania 262
FR - Francia 210
BD - Bangladesh 174
IN - India 174
CA - Canada 128
NL - Olanda 118
GB - Regno Unito 117
JP - Giappone 98
KR - Corea 91
FI - Finlandia 88
ES - Italia 72
MX - Messico 71
AR - Argentina 58
UA - Ucraina 45
IQ - Iraq 39
PH - Filippine 35
PL - Polonia 35
ZA - Sudafrica 34
IE - Irlanda 32
EC - Ecuador 29
PK - Pakistan 26
TH - Thailandia 26
SE - Svezia 24
AT - Austria 23
ID - Indonesia 21
TR - Turchia 20
CI - Costa d'Avorio 19
TW - Taiwan 16
JO - Giordania 15
LT - Lituania 15
UZ - Uzbekistan 13
JM - Giamaica 12
VE - Venezuela 12
EG - Egitto 11
MA - Marocco 10
RO - Romania 10
CL - Cile 9
CO - Colombia 9
NP - Nepal 9
PE - Perù 9
BE - Belgio 8
CH - Svizzera 8
DZ - Algeria 8
KE - Kenya 8
MY - Malesia 8
RS - Serbia 8
SA - Arabia Saudita 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
PY - Paraguay 7
AZ - Azerbaigian 6
CR - Costa Rica 6
GR - Grecia 5
HU - Ungheria 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
BS - Bahamas 4
CZ - Repubblica Ceca 4
HN - Honduras 4
PT - Portogallo 4
SV - El Salvador 4
UY - Uruguay 4
EE - Estonia 3
GA - Gabon 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
TZ - Tanzania 3
AD - Andorra 2
BM - Bermuda 2
BN - Brunei Darussalam 2
ET - Etiopia 2
GD - Grenada 2
GF - Guiana Francese 2
IR - Iran 2
KN - Saint Kitts e Nevis 2
LY - Libia 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 16.563
Salva come PNG Salva come JPEG
Città #
Singapore 1.441
San Jose 1.087
Hong Kong 548
Ashburn 515
Moscow 449
Hefei 388
Chandler 381
Ho Chi Minh City 290
Beijing 275
Hanoi 233
Naples 217
Santa Clara 170
Council Bluffs 151
Los Angeles 148
Lauterbourg 146
The Dalles 140
Millbury 107
Munich 100
Milan 94
Lawrence 89
New York 85
Tokyo 85
Des Moines 79
Seoul 74
Redondo Beach 71
São Paulo 70
Buffalo 65
Kochi 63
Rome 63
Napoli 62
Dallas 57
Haiphong 51
Helsinki 51
Amsterdam 46
Boston 45
Wilmington 44
Frankfurt am Main 42
Valencia 40
Da Nang 39
Orem 37
Phoenix 35
Chicago 34
Montreal 31
Atlanta 30
Seattle 30
Chennai 28
Brooklyn 25
Falkenstein 24
London 23
Mexico City 23
Rio de Janeiro 23
Biên Hòa 22
Nanjing 22
Ottawa 22
Warsaw 22
Toronto 21
Fairfield 20
Johannesburg 20
Baghdad 19
Dublin 19
Houston 19
Can Tho 18
Turku 17
Denver 16
Nuremberg 16
Stockholm 16
Hải Dương 15
San Francisco 15
Amman 14
Belo Horizonte 12
Bologna 12
Brasília 12
Lappeenranta 12
Princeton 12
Turin 12
Ankara 11
Düsseldorf 11
Ninh Bình 11
Redwood City 11
Bari 10
Curitiba 10
Salerno 10
Tashkent 10
Bangkok 9
Florence 9
Kronberg 9
Memphis 9
Quito 9
Shanghai 9
Charlotte 8
Guangzhou 8
Guayaquil 8
Karachi 8
Messina 8
Miami 8
Philadelphia 8
Pune 8
Roubaix 8
Salt Lake City 8
Vienna 8
Totale 9.075
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 226
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 190
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 186
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 176
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 168
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 161
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 161
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 158
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 157
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 157
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 157
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 156
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 154
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 153
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 151
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 150
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 150
Role of Cytomorphology in the Era of Liquid Biopsy 148
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 147
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 147
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 146
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 146
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 145
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 143
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 141
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 140
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 139
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 138
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 138
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 137
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 136
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 136
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 136
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 135
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 134
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 134
The role of liquid biopsy in epithelial ovarian cancer: state of the art 133
Next generation sequencing in cytology 133
Tumor mutational burden on cytological samples: A pilot study 132
Predictive molecular pathology in the time of COVID-19 131
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 131
Methods for actionable gene fusion detection in lung cancer: now and in the future 131
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 130
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 130
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 129
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 128
Brca1/2 ngs somatic testing in clinical practice: a short report 128
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 127
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 127
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 127
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 126
The evolving role of liquid biopsy in lung cancer 125
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 125
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 124
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 123
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories 123
Osimertinib 123
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 123
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 122
BRAF: A Two-Faced Janus 122
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 121
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 121
BRAF mutations in lung cancer 121
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 120
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 119
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 119
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 119
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 118
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 118
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 117
Interobserver variability in cytopathology: How much do we agree? 116
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 116
How to prepare cytological samples for molecular testing 115
Invited review—next-generation sequencing: a modern tool in cytopathology 115
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 115
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 115
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 114
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 114
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 113
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 111
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 109
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 108
Liquid Biopsy and Lung Cancer 108
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 108
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 106
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 106
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 104
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 104
Liquid biopsy testing in urological cancers: Focus on urine 103
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 103
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 102
Liquid Biopsy in Solid Tumours: An Overview 102
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 102
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 101
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer 99
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 95
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 95
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 93
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 93
Juggling the COVID-19 pandemic: A cytopathology point of view 92
Totale 12.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022566 0 0 21 9 11 12 16 69 22 51 132 223
2022/2023923 116 58 40 67 125 115 4 107 172 44 58 17
2023/2024713 42 123 50 29 29 37 25 98 22 38 127 93
2024/20254.400 204 235 21 22 99 191 465 275 306 621 1.563 398
2025/20268.992 861 795 911 779 1.419 360 1.032 587 1.033 585 285 345
2026/2027633 226 398 9 0 0 0 0 0 0 0 0 0
Totale 16.869